Home > Analytics > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
Intrinsic Value | Fundamental Analysis

BOM :      NSE : PAR    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
Mar 28,2023
Price(EOD): ₹ 129.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Chemicals
MCap: ₹ 158.85 Cr
Value of ₹ 1 Lac invested in PAR DRUGS AND CHEMICALS
on May 16,2019 (price: ₹ 50.45)

₹ 1 L

₹ 2.56 L

1W : -8.1% 1M : -12.2% 1Y : -20.3%
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
PAR DRUGS AND CHEMICALS -8.1% -12.2% -20.3%
PIDILITE INDUSTRIES -1.9% 2.5% -4.3%
SOLAR INDUSTRIES (INDIA) -4.3% -4% 42.3%
GUJARAT FLUOROCHEMICALS -7.4% -5.5% 2.8%
DEEPAK NITRITE -0.4% -0.9% -19.5%
TATA CHEMICALS -0.8% -2% -2.1%
ATUL -0.4% -2.3% -31%
AARTI INDUSTRIES -5.6% -8.7% -46.6%
NAVIN FLUORINE INTERNATIONAL -1% -1.4% 4.9%

FUNDAMENTAL ANALYSIS OF PAR DRUGS AND CHEMICALS

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF PAR DRUGS AND CHEMICALS

 
Valuation Score
[As on : Mar 28,2023 ]

Ratio Standalone
P/E
P/B
P/S
15.41
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 10.31 Cr
[Latest Qtr - Dec2022 - Standalone Results ]

2.65
P/B Calculated based on Book Value of Rs 59.88 Cr
[Latest Year - Mar2022 - Standalone Results ]

1.7
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 34% undervalued companies ! Discover More →

FAIR VALUE OF PAR DRUGS AND CHEMICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
48%
46%
8%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF PAR DRUGS AND CHEMICALS



PAR DRUGS AND CHEMICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF PAR DRUGS AND CHEMICALS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0
0.16
0.15
0.1
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF PAR DRUGS AND CHEMICALS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF PAR DRUGS AND CHEMICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-7.6%
-45.26%
-49.83%
-49.81%
35.57%
-9.21%
-8.77%
-11.59%
QtrlyTrend
-6
Latest Qtr: Dec2022
Quarterly Result Analysis →


PAR DRUGS AND CHEMICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about PAR DRUGS AND CHEMICALS


Is PAR DRUGS AND CHEMICALS good for long term investment?

As on Mar 28,2023, the Fundamentals of PAR DRUGS AND CHEMICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of PAR DRUGS AND CHEMICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is PAR DRUGS AND CHEMICALS UnderValued or OverValued?

As on Mar 28,2023, PAR DRUGS AND CHEMICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of PAR DRUGS AND CHEMICALS ?

As on Mar 28,2023, the Intrinsic Value of PAR DRUGS AND CHEMICALS is Rs. 88.62 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 87.47
Fair Value [Median EV / Sales Model] : Rs. 88.62
Fair Value [Median Price / Sales Model] : Rs. 119.68
Estimated Median Fair Value of PAR DRUGS AND CHEMICALS : Rs. 88.62

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is PAR DRUGS AND CHEMICALS trading at a Premium or Discount?

As on Mar 28,2023, PAR DRUGS AND CHEMICALS is trading at a Premium of 46% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].